Skip to content

Clinical study for the effect of Zhizhen Fang on postoperative adjuvant chemotherapy in patients with stage III colorectal cancer

A randomized controlled trial was conducted to study the clinical effect of Zhizhen Fang on postoperative adjuvant chemotherapy for stage III colorectal cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036779
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) The pathological diagnosis was consistent with colorectal cancer and the clinicopathological stage was stage III post operation; (2) The syndrome differentiation was in accordance with the TCM syndrome of spleen deficiency and qi stagnation; (3) Patients with chemotherapy indications and initial chemotherapy after operation; (4) The KPS score was above 60; (5) The age ranged from 18 to 75 years old; (6) The expected survival time was more than 6 months; (7) The function of important organs was normal, blood routine test, liver and kidney function and electrocardiogram were normal; (8) There was no abnormal mental state, who could understand and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Combined with important organ or blood system diseases; (2) Severe allergic constitution; (3) Pregnant or lactating women; (4) There are mental disorders and can not cooperate.

Design outcomes

Primary

MeasureTime frame
Judgment of TCM syndrome curative effect;

Countries

China

Contacts

Public ContactHuijie Han

Shanghai General Hospital

hanhuijie601@163.com+86 13761390065

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026